Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

Global markets on their toes due to COVID-19 reinfections - Wednesday Review, August 26

Global markets on their toes due to COVID-19 reinfections - Wednesday Review, August 26

Markets mixed ahead of Jerome Powell’s speech

The US

The benchmarks were in for a treat yesterday. The stocks were moved by gains in the tech sector, as Salesforce posted better-than-expected Q2 earnings, and FAANG (Facebook, Amazon, Apple, Netflix, and Google) gained more than 17%. USA30 rose 0.30%, while USA500 gained 1.03%. TECH100 added 1.73%.

Oil gained 0.04% to $43.39 per barrel. Brent Oil went up 0.5% at $45.64.

Gold settled up 1.5% at $1,952.50 per ounce, marking the first gain in a week.

Asia and Australia

Investors’ caution over the spike in COVID-19 cases made the markets lose some steam.

HongKong45 lost 0.20%, although the country expects the lockdown measures to relax.

Japan225 edged down 0.20%.

Australia200 fell 0.92% after Victoria state reported 24 new COVID-19 deaths and 149 new cases.

USD/JPY lost 0.08% and settled at 106.28.

Europe

The markets were mixed yesterday, gains being caused by the touted speech of the US Federal Reserve Chairman Jerome Powell, while the losses appeared due to two confirmed cases of COVID-19 reinfection.

Europe50 and France40 traded 0.1% higher. Germany30 rose 0.2%, while UK100 was down 0.2%.

EUR/USD lost 0.1% and traded at 1.1820.

Sources: investing.com, reuters.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com